0:00
NaN:NaN:NaN
FDA medical oncologists discuss the July 7, 2017, approval of l-glutamine to reduce the acute complications of sickle cell disease.
Released August 17, 2017
Flere episoder fra "FDA Drug Information Updates"
Gå ikke glip af nogen episoder af “FDA Drug Information Updates” - abonnér på podcasten med gratisapp GetPodcast.